Runben Biotechnology Co., Ltd. (SHA:603193)
16.07
-0.82 (-4.85%)
Nov 20, 2026, 3:00 PM CST
Runben Biotechnology Market Cap
Runben Biotechnology has a market cap or net worth of 6.5 billion as of November 20, 2026. It is the 9,662nd most valuable company in the world and the 2,053rd biggest in China. Its market cap has decreased by 35.49% in one year.
Market Cap
6.50B
Enterprise Value
5.06B
Revenue
1.71B
Global Rank
Country Rank
#2,053 China
PE Ratio
18.67
ChartMarket Cap Chart
Since October 17, 2023, Runben Biotechnology's market cap has decreased from 8.93B to 6.50B, a decrease of -27.22%. That is a compound annual growth rate of -9.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 6.50B | -33.68% |
| Dec 31, 2025 | 9.80B | 3.77% |
| Dec 31, 2024 | 9.45B | 28.44% |
| Dec 29, 2023 | 7.36B | -17.66% |
| Oct 17, 2023 | 8.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yunnan Botanee Bio-Technology Group Co.LTD | 10.82B |
| Guangdong Marubi Biotechnology | 10.60B |
| Shanghai Jahwa United | 10.51B |
| Harbin Fuerjia Technology | 10.00B |
| C&S Paper Co.,Ltd | 9.09B |
| Chongqing Baiya Sanitary Products | 8.62B |
| Dencare (Chongqing) Oral Care | 6.12B |
| Lushang Freda Pharmaceutical | 4.96B |